These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18316438)

  • 21. [Drug therapy of opioid withdrawal].
    Cortese S; Risso M
    Vertex; 2008; 19(77):522-6. PubMed ID: 18443666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transdermal buprenorphine and silent acute coronary syndrome].
    Vidal MA; Calderón E; Pernia A; Calderón-Pla E; Torres LM
    Rev Esp Anestesiol Reanim; 2006 Jan; 53(1):58-9. PubMed ID: 16475644
    [No Abstract]   [Full Text] [Related]  

  • 23. Case Report: Buprenorphine Induction Using Transdermal Buprenorphine in a Veteran With Opioid Use Disorder and Psychosis, Managing Precipitated Withdrawal.
    Kinasz KR; Herbst ED; Kalapatapu RK
    Mil Med; 2020 Sep; 185(9-10):e1872-e1875. PubMed ID: 32314788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged-release naloxone can cause systemic opioid withdrawal.
    Wilcock A
    Eur J Pain; 2009 Oct; 13(9):1001; author reply 1002-3. PubMed ID: 19615925
    [No Abstract]   [Full Text] [Related]  

  • 25. Kratom and opioid use disorder in the perioperative period: A case report on the expanding role of buprenorphine.
    Perez J
    J Opioid Manag; 2023; 19(1):91-93. PubMed ID: 36683304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-hyperalgesia properties of buprenorphine.
    Russo MA
    Pain; 2006 May; 122(1-2):216; author reply 216. PubMed ID: 16524662
    [No Abstract]   [Full Text] [Related]  

  • 27. [Erroneous opinions refuted. New knowledge about an old effective substance].
    MMW Fortschr Med; 2006 Jan; 148(1-2):42. PubMed ID: 16610414
    [No Abstract]   [Full Text] [Related]  

  • 28. Takotsubo cardiomyopathy associated with buprenorphine precipitated withdrawal.
    Surmaitis RM; Khalid MM; Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2018 Sep; 56(9):863-864. PubMed ID: 29433361
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol withdrawal: a systematic review.
    Lozano-López MT; Gamonal-Limcaoco S; Casado-Espada N; Aguilar L; Vicente-Hernández B; Grau-López L; Álvarez-Navares A; Roncero C
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(13):4554-4562. PubMed ID: 34286498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent Takotsubo Cardiomyopathy Associated with Opioid Withdrawal During Buprenorphine Induction.
    Jamshidi N; Clark D; Murnion B
    Cardiovasc Toxicol; 2021 May; 21(5):349-353. PubMed ID: 33481183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of a opioid dependence in a not diagnosed restless legs syndrome].
    Hain C
    Psychiatr Prax; 2002 Sep; 29(6):322-3. PubMed ID: 12402965
    [No Abstract]   [Full Text] [Related]  

  • 32. Suspected takotsubo cardiomyopathy caused by withdrawal of bupirenorphine in a child.
    Maruyama S; Nomura Y; Fukushige T; Eguchi T; Nishi J; Yoshinaga M; Kawano Y
    Circ J; 2006 Apr; 70(4):509-11. PubMed ID: 16565573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opiate treatment in depression refractory to antidepressants and electroconvulsive therapy.
    Nyhuis PW; Gastpar M; Scherbaum N
    J Clin Psychopharmacol; 2008 Oct; 28(5):593-5. PubMed ID: 18794671
    [No Abstract]   [Full Text] [Related]  

  • 35. Should opioid abusers be discharged from opioid-analgesic therapy?
    Compton P
    Pain Med; 2008; 9(4):383-90. PubMed ID: 18489627
    [No Abstract]   [Full Text] [Related]  

  • 36. [Withdrawal symptoms following treatment with tramadol].
    Sandqvist A; Dahlqvist R
    Lakartidningen; 2009 Feb 18-24; 106(8):520-1. PubMed ID: 19350787
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clonidine in opiate withdrawal. II. Potential side-effects].
    Keup W
    MMW Munch Med Wochenschr; 1982 Feb; 124(7):153-5. PubMed ID: 6801495
    [No Abstract]   [Full Text] [Related]  

  • 38. [A recurrent case of psychotic withdrawal syndrome caused by monoamine oxidase inhibitors?].
    Sáez I; Jiménez F
    Med Clin (Barc); 1984 May; 82(19):864-5. PubMed ID: 6738220
    [No Abstract]   [Full Text] [Related]  

  • 39. Severe, Nondelirium Agitation as an Underreported Characteristic of Precipitated Fentanyl Withdrawal: A Case Report.
    Terasaki D; Brady J
    J Addict Med; 2023 Jan-Feb 01; 17(1):111-113. PubMed ID: 35914120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using buprenorphine short-term taper to facilitate early treatment engagement.
    Brigham GS; Amass L; Winhusen T; Harrer JM; Pelt A
    J Subst Abuse Treat; 2007 Jun; 32(4):349-56. PubMed ID: 17481458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.